2027 RHP Damian Webb (Oliver Wolcott Tech, CT) // @RutgersBaseball commit
Towering 6’8 frame. Attacks with a power FB and mixes in the CB and a ++ CH
FB: 91-93
CB: 81-83
CH: 86-87
@EbertBaseball | @ShooterHunt
Wolcott Tech’s Damian Webb (@RutgersBaseball commit) hit 93mph multiple times today.
The 6’8” righty pitched 5 shutout innings, allowing one hit and one walk while striking out 11 with his heat and slider combo #ctbase
#Rutgers Nation, time to step up.
For each repost/like of this post through tomorrow I will donate $52 to @RUAthletics and @R_Fund.
Please join me, spread the word and #MaxOutTheMillionMatch.
Donate here: https://t.co/3QMQxOUWBn
‘27 Damien Webb (CT) running his fastball up to 88 mph early on w/ an 11/5 curveball to pair. 6’8” frame w/ plenty to dream on. #Rutgers commit.
#WWBAWorlds@PG_NewEngland
@rutgersbaseball commit (class of 2027) Damian Webb had a solid start in quarterfinals for @cbabaseballorg picking up the win over Team Elite. Webb was 87-89 T92 with his FB With a 2000 sr and 2200 sr on his slider.
5 ip, 5ks, 2er an 3BB
𝗦𝗰𝗼𝘂𝘁 𝗗𝗮𝘆: 𝗪𝗼𝘄 𝗙𝗮𝗰𝘁𝗼𝗿 𝗘𝗮𝘀𝘁 𝗖𝗼𝗮𝘀𝘁
𝓣𝓸𝓹 𝓟𝓮𝓻𝓯𝓸𝓻𝓶𝓮𝓻𝓼
👤 2027 Damian Webb (CT)
🔗 https://t.co/Fr8tZJ3o6t
📝 A two-way player, fastball up to 88 mph, heavy cut action to fastball, showed the ability to throw splitter for a swing and miss pitch. Exit Velocity was up to 102 mph.
@WowFactorEC | @PB_Uncommitted
.@PG_NewEngland presents Damian Webb (‘27, CT) with a Perfect Game #TopPerformerTuesday baseball card! ⚾️
Webb slugged .815 w/ 9 💣 & 40 RBI in 44 games. He also posted a 2.57 ERA w/ 45 Ks thru 30 IP at PG events in ‘24. 🔥
@PG_Scouting@PG_Tourney
They want to silence me because I will never let them silence you. They’re not coming after me, they’re coming after you. I just happen to be standing in their way and I'm never moving.
We will Make America Great Again! #TrumpOnX
Honored to be featured on the cover of BGN Global Magazine!!
Breaking Stereotypes: From North America to the Middle East!!
https://t.co/OiRpmIX1om
@MuhammadBoneSaw@hrhprincesshaya
Ocugen announces DSMB approval to proceed with dosing the high dose of OCU410ST in the Phase 1/2 GARDian clinical trial. Read more here: https://t.co/OfDhHYn1hV